Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.
- DOI
- 10.1111/nyas.12567
- Published
- 2014 Nov
- Container
- Annals of the New York Academy of Sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/nyas.12567,
title = {Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.},
author = {Hanna MS and Mohan P and Knabb R and Gupta E and Frost C and Lawrence JH},
year = {2014},
journal = {Annals of the New York Academy of Sciences},
doi = {10.1111/nyas.12567},
url = {https://doi.org/10.1111/nyas.12567}
}RIS
TY - JOUR TI - Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation. AU - Hanna MS AU - Mohan P AU - Knabb R AU - Gupta E AU - Frost C AU - Lawrence JH PY - 2014 JO - Annals of the New York Academy of Sciences DO - 10.1111/nyas.12567 UR - https://doi.org/10.1111/nyas.12567 ER -
APA
MS, H., P, M., R, K., E, G., C, F., & JH, L. (2014). Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.12567
Source records
- pubmed · retrieved 2026-09-27T08:10:28.570Z